We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genzyme Sues Eagle Pharma Over Hectorol ANDA

Law360 (April 24, 2009, 12:00 AM EDT) -- Biotechnology firm Genzyme Corp. has filed a lawsuit accusing Eagle Pharmaceuticals Inc. of infringing a method patent for the use of hormone disorder drug Hectorol by seeking approval to sell a generic version of the treatment.

On Thursday, Genzyme and its wholly owned company Bone Care International LLC filed suit in the U.S. District Court for the District of Delaware, alleging infringement of U.S. Patent Number 5,602,116, titled “Method for treating and preventing secondary hyperparathyroidism” and owned by Bone Care.

According to Genzyme, the patent claims...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.